Expert Webinar: Technology and Fundamentals in Using MicroLC-MS/MS


Whether you are looking to increase sensitivity, if your applications suffer from sample amount, or if you are an applied proteomics researcher in need of enhanced robustness, then MicroLC-MS is the solution for you.
On the one hand, MicroLC-MS can enable you to achieve your LLOQs while working with smaller animal models, for example. Alternatively, it can also help you gain robustness of analytical flow LC-MS for large sample cohorts. In all cases, using MicroLC-MS will allow you to achieve quantitation over a larger linear dynamic range, all while decreasing operating costs and increasing your lab’s efficiency.
Register to attend!
February 6, 2020 | 4 p.m. CET
Who should attend the Webinar?
All LC-MS users, independent from the market application.
Key Learning Objectives
This webinar will explain the basics and benefits of MicroLC:
- What is the physical background?
- How can it technically be realized?
- Where does the improvements in sensitivity come from?
- What additional benefits can be expected?
Webinar Speakers:
Dr. Thorsten Teutenberg
Institute of Energy and Environmental Technology (IUTA)
Rolf Kern
SCIEX
most read

The Future of Demand for Chemicals
The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Specialty Chemicals in a Shifting World
Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

“Access to Talent is a Crucial Factor”
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Pharma Outlook 2025
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.








